These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1207 related items for PubMed ID: 26023239

  • 1. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H, Takita M, Saruwatari K, Umemura S, Obata Y, Ishii G, Matsumoto S, Sugiyama E, Ochiai A, Abe R, Goto K, Esumi H, Tsuchihara K.
    J Biol Chem; 2015 Jul 10; 290(28):17495-504. PubMed ID: 26023239
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma.
    Makinoshima H, Takita M, Matsumoto S, Yagishita A, Owada S, Esumi H, Tsuchihara K.
    J Biol Chem; 2014 Jul 25; 289(30):20813-23. PubMed ID: 24928511
    [Abstract] [Full Text] [Related]

  • 3. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
    Jeannot V, Busser B, Brambilla E, Wislez M, Robin B, Cadranel J, Coll JL, Hurbin A.
    Int J Cancer; 2014 Jun 01; 134(11):2560-71. PubMed ID: 24374738
    [Abstract] [Full Text] [Related]

  • 4. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway.
    Wang S, Cheng Z, Cui Y, Xu S, Luan Q, Jing S, Du B, Li X, Li Y.
    J Transl Med; 2023 Nov 16; 21(1):819. PubMed ID: 37974250
    [Abstract] [Full Text] [Related]

  • 5. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
    Lee KY, Shueng PW, Chou CM, Lin BX, Lin MH, Kuo DY, Tsai IL, Wu SM, Lin CW.
    Cancer Sci; 2020 May 16; 111(5):1652-1662. PubMed ID: 32133706
    [Abstract] [Full Text] [Related]

  • 6. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ.
    J Vasc Surg; 2013 Feb 16; 57(2):475-85. PubMed ID: 23265586
    [Abstract] [Full Text] [Related]

  • 7. Hydroxysafflor Yellow A Promotes HaCaT Cell Proliferation and Migration by Regulating HBEGF/EGFR and PI3K/AKT Pathways and Circ_0084443.
    Zhang Y, Xiao YW, Ma JX, Wang AX.
    Chin J Integr Med; 2024 Mar 16; 30(3):213-221. PubMed ID: 37688744
    [Abstract] [Full Text] [Related]

  • 8. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K, Luo J, Shao C, Ren Z, Sun S, Zhu Y, Zhou H, Jiang Z, Li X, Gu W, Xu Y, Qiang Y, Ren B, Xu L, Wu H, Shen Y.
    Med Sci Monit; 2020 Feb 28; 26():e920351. PubMed ID: 32108133
    [Abstract] [Full Text] [Related]

  • 9. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
    Wu YY, Wu HC, Wu JE, Huang KY, Yang SC, Chen SX, Tsao CJ, Hsu KF, Chen YL, Hong TM.
    J Exp Clin Cancer Res; 2019 Jul 01; 38(1):282. PubMed ID: 31262325
    [Abstract] [Full Text] [Related]

  • 10. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
    Liu Y, Zhao Y, Guo L.
    Mol Cell Endocrinol; 2016 Jan 15; 420():208-16. PubMed ID: 26549689
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z, Yang Z, Passaniti A, Lapidus RG, Liu X, Cullen KJ, Dan HC.
    Oncotarget; 2016 May 31; 7(22):31892-906. PubMed ID: 26895469
    [Abstract] [Full Text] [Related]

  • 18. Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness.
    Li X, Ishihara S, Yasuda M, Nishioka T, Mizutani T, Ishikawa M, Kawabata K, Shirato H, Haga H.
    PLoS One; 2013 May 31; 8(8):e70905. PubMed ID: 23951036
    [Abstract] [Full Text] [Related]

  • 19. mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme.
    Ramaiah MJ, Kumar KR.
    Mol Biol Rep; 2021 May 31; 48(5):4813-4835. PubMed ID: 34132942
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E, Troiani T, D'Aiuto E, Morgillo F, Vitagliano D, Capasso A, Costantino S, Ciuffreda LP, Merolla F, Vecchione L, De Vriendt V, Tejpar S, Nappi A, Sforza V, Martini G, Berrino L, De Palma R, Ciardiello F.
    Int J Cancer; 2013 Nov 31; 133(9):2089-101. PubMed ID: 23629727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.